6-甲氧基二氢吲哚 | 7556-47-0

• 物质功能分类: 医药中间体 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 6-甲氧基二氢吲哚
• 中文别名: 2,3-二氢-6-甲氧基-1H-吲哚；6-甲氧基吲哚啉
• 英文名称: 6-methoxy-2,3-dihydro-1H-indole
• 英文别名: 6-methoxy-indoline；6-Methoxy-indolin；6-Methoxyindoline
• CAS: 7556-47-0
• 化学式: C₉H₁₁NO
• mdl: MFCD07371636
• 分子量: 149.192
• InChiKey: GKFGHNMPMAXWQS-UHFFFAOYSA-N

物化性质

• 沸点：
  135-137 °C(Press: 14 Torr)
• 密度：
  1.076±0.06 g/cm3(Predicted)
• 保留指数：
  1503;1515

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P310,P332+P313,P362,P403+P233,P405,P501
• 危险品运输编号：
  2735
• 危险性描述：
  H315,H318,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Methoxyindoline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Methoxyindoline
CAS number: 7556-47-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H11NO
Molecular weight: 149.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-甲氧基二氢吲哚 在 硼烷四氢呋喃络合物 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 24.5h， 生成 1-ethyl-6-methoxyindoline
  参考文献：
  名称：

  [EN] NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION
  [FR] FORMULATIONS DE FLUOROPHORE SPÉCIFIQUE AUX NERFS POUR ADMINISTRATION DIRECTE ET SYSTÉMIQUE

  摘要：

  描述了用于直接或全身给药的神经特异性荧光素配方。这些配方可用于荧光引导手术（FGS），帮助在外科手术干预期间保护神经。

  公开号：

  WO2020033435A1
• 作为产物：
  描述：

  4-氯-3-硝基苯甲醚 在 palladium on activated charcoal 氢气 、 potassium carbonate 、 溶剂黄146 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 25.0~70.0 ℃ 、344.74 kPa 条件下， 反应 42.0h， 生成 6-甲氧基二氢吲哚
  参考文献：
  名称：

  吲哚的简单两步合成

  摘要：

  摘要 描述了适合大规模使用的吲哚的两步合成。还简要探讨了这种方法的普遍适用性。

  DOI：

  10.1081/scc-120021501

文献信息

• [EN] HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME<br/>[FR] COMPOSÉS HÉTÉROARYLE UTILES EN TANT QU'INHIBITEURS DE L'ENZYME D'ACTIVATION SUMO
  申请人：DUFFEY MATTHEW O

  公开号：WO2016004136A1

  公开（公告）日：2016-01-07

  Disclosed are chemical entities which are compounds of formula (I); or pharmaceutically acceptable salts thereof; wherein Y, Ra, Ra', Rb, Rc, X1, X2, X3, Rd, Z1, and Z2 have the values described herein and stereochemical configurations depicted at asterisked positions indicate absolute stereochemistry. Chemical entities according to the disclosure can be useful as inhibitors of Sumo Activating Enzyme (SAE). Further provided are pharmaceutical compositions comprising a compound of the disclosure and methods of using the compositions in the treatment of proliferative, inflammatory, cardiovascular, and neurodegenerative diseases or disorders.

  公开了公式(I)的化合物或其药物可接受的盐； 其中Y、Ra、Ra'、Rb、Rc、X1、X2、X3、Rd、Z1和Z2具有本文所述的值，并且星号位置表示的立体化学配置指示绝对立体化学。 根据本公开的化学实体可用作Sumo激活酶（SAE）的抑制剂。 进一步提供了包含本公开化合物的药物组合物以及使用该组合物治疗增殖性、炎症性、心血管和神经退行性疾病或病症的方法。
• [EN] INDOLINE COMPOUNDS<br/>[FR] COMPOSÉS INDOLINIQUES
  申请人：FERRER INT

  公开号：WO2009053440A1

  公开（公告）日：2009-04-30

  This invention provides new 2,3-dihydro-indole compounds, their use for the treatment or prevention of melatoninergic disorders and its compositions.

  本发明提供了新的2,3-二氢吲哚化合物，它们用于治疗或预防褪黑素能障碍以及其组合物。
• [EN] 2- [ (2-{PHENYLAMINO}-1H-PYRROLO [2, 3-D] PYRIMIDIN-4-YL) AMINO] BENZAMIDE DERIVATIVES AS IGF-1R INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE 2-[(2-{PHÉNYLAMINO}-1H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]BENZAMIDE EN TANT QU'INHIBITEUR D'IGF-1R POUR LE TRAITEMENT DU CANCER
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2009020990A1

  公开（公告）日：2009-02-12

  Novel pyrrolopyrimidines as shown in formula (I) and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.

  新型吡咯吡嘧啶如公式(I)所示，及其药用可接受的衍生物。这些化合物在抑制IGF-1R方面是有用的。
• Potassium <i>tert</i> ‐Butoxide‐Promoted Acceptorless Dehydrogenation of N‐Heterocycles
  作者：Tingting Liu、Kaikai Wu、Liandi Wang、Zhengkun Yu

  DOI：10.1002/adsc.201900499

  日期：2019.9.3

  Potassium tert‐butoxide‐promoted acceptorless dehydrogenation of N‐heterocycles was efficiently realized for the generation of N‐heteroarenes and hydrogen gas under transition‐metal‐free conditions. In the presence of KOtBu base, a variety of six‐ and five‐membered N‐heterocyclic compounds efficiently underwent acceptorless dehydrogenation to afford the corresponding N‐heteroarenes and H2 gas in o‐xylene

  钾叔N-杂环的丁醇促进的acceptorless脱氢高效地实现用于N-杂芳烃和氢气的过渡金属-自由条件下产生。在存在KO t Bu碱的情况下，各种六元和五元N-杂环化合物可以有效地进行无受体脱氢，从而在140°C的邻二甲苯中提供相应的N-杂芳烃和H 2气体。本协议提供了一条通往芳香族含氮化合物和H 2气体的便捷途径。
• Covalent Organic Frameworks toward Diverse Photocatalytic Aerobic Oxidations
  作者：Shuyang Liu、Miao Tian、Xiubin Bu、Hua Tian、Xiaobo Yang

  DOI：10.1002/chem.202100398

  日期：2021.5.17

  two‐dimensional covalent organic frameworks (2D‐COFs) have become promising heterogenous photocatalysts in visible‐light‐driven organic transformations. Herein, a visible‐light‐driven selective aerobic oxidation of various small organic molecules by using 2D‐COFs as the photocatalyst was developed. In this protocol, due to the remarkable photocatalytic capability of hydrazone‐based 2D‐COF‐1 on molecular

  在可见光驱动的有机转化中，光活性二维共价有机骨架（2D-COF）已成为有前途的多相光催化剂。在此，通过使用二维COFs作为光催化剂，开发了可见光驱动的各种有机小分子的选择性好氧氧化。在该方案中，由于2D-COF-1对分子氧活化具有非凡的光催化能力，因此在非常温和的条件下获得了高效，优异的官能团耐受性的各种酰胺，喹诺酮，杂环化合物和亚砜。反应条件。此外，得益于多相光催化的固有优势，突出的可持续性和易于光催化的可回收性，在按比例放大反应中，有选择地轻松获得了一种药物分子（莫达非尼）和一种氧化芥子气模拟物（2-氯乙基乙基亚砜）。使用自由基猝灭实验和原位ESR光谱进行了机理研究，证实了2D-COF-1在光催化循环中的作用。